Study details
Enrolling now
4-Aminopyridine Treatment for Nerve Injury
John Elfar
NCT IDNCT03701581ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2/3
Target enrollment
70
Study length
about 7.6 years
Ages
45–75
Sex
Male only
Locations
2 sites in AZ, NY
What this study is about
This trial is testing whether 4-aminopyridine (4-AP) can help with recovery after nerve injuries. The treatment will be compared to a placebo.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Placebo
- 2.Take 4-Aminopyridine
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
fampridine
Endpoints
Primary: Michigan Incontinence Sympton Index (M-ISI) (change over time)
Body systems
Oncology